Status:

Do Not Prescribe (DNP), Red

Decision Date:

May 2021

Comments

RED8: NICE TA698 - Treatment of adults with paroxysmal nocturnal haemoglobinuria with haemolysis with clinical symptoms indicative of high disease activity and those treated with eculizumab for 6 months who are clinically stable. (Decision date - June 2021) 

RED8: NICE TA710 - Ravulizumab for treating atypical haemolytic uraemic syndrome (Decision date - July 2021)

DNP: NICE TA940 - for treating generalised myasthenia gravis (terminated appraisal) (Decision date - January 2024)

DNP: NICE TA941 - for treating AQP4 antibody-positive neuromyelitis optica spectrum disorder (terminated appraisal) (Decision date - January 2024)

Red Drug Classifications

• 8. NHS England commissioned – to be used in line with NHSE commissioning intentions

search again